Apogee Therapeutics signaled a “best case scenario” on Monday for its experimental eczema treatment, ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the ...

What causes it, how it looks on different skin tones, and an available biologic treatment option that can be used with or ...

Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects millions of children and adults. It often causes itching, redness, dryness, flaking, and sometimes ...

Delgocitinib is the first FDA-approved topical JAK inhibitor for moderate to severe chronic hand eczema in adults. The DELTA 1 and DELTA 2 studies showed significant efficacy, with improved patient ...

A clinical review breaks down the latest best practices for managing severe atopic dermatitis (AD) in pregnancy. The review, which appears in Clinical Medicine, was developed by a team of British ...

An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema). The findings ...

Treatment options for severe chronic hand eczema are limited and carry troublesome adverse effects. Delgocitinib cream had superior efficacy compared with oral alitretinoin for this patient population ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE As someone with eczema, Ive used ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...